Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 9, 2017 - Issue
Submit an article Journal homepage
98
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK

Michele R Wilson1 RTI Health Solutions, Research Triangle Park, NC, USACorrespondence[email protected]
,
Ismail Azzabi Zouraq2 Takeda Pharmaceuticals International AG, Zurich, Switzerland
,
Helene Chevrou-Severac2 Takeda Pharmaceuticals International AG, Zurich, Switzerland
,
Ross Selby3 Takeda UK Ltd., Bucks, UK
&
Matthew C Kerrigan4 PHMR Limited, London, UK
Pages 641-652 | Published online: 16 Oct 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.